Clinical Trials Directory

Trials / Completed

CompletedNCT03611660

Does Mindfulness Enhance BMI in Obese Adolescents Enrolled in the Bright Bodies Weight Management Program?

Does the Addition of Mindfulness Enhance BMI Outcomes in Obese Adolescents Enrolled in the Bright Bodies Weight Management Program?

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
42 (actual)
Sponsor
Yale University · Academic / Other
Sex
All
Age
11 Years – 17 Years
Healthy volunteers
Not accepted

Summary

Participants will be randomized to an evidence-based healthy lifestyle program alone or a healthy lifestyle program with mindfulness meditation added. The purpose of the study will be to determine if mindfulness improves BMI outcomes more than the program alone due to the stress-reduction benefits of mindfulness.

Detailed description

The study will randomize 44 adolescents (aged 11-17 yo) with BMI \>95th percentile to traditional Bright Bodies Healthy Lifestyle Program or Lifestyle Program plus mindfulness meditation (6 sessions within the 12-week program) (22 per group). The traditional program includes exercise two evenings per week and nutrition/behavior modification one evening per week for 12 weeks. Mindfulness session topics include breathing meditation, body scan meditation, mindful eating techniques, and identification of hunger verses satiation. The primary outcome measure with be (1) BMI, while secondary outcomes include changes in (2) percent body fat, (3) perceived stress scale (questionnaire), (4) physical stress (saliva cortisol levels), and (5) overall caloric intake (pre and post food records). After the 3 month intervention, participants will engage in post measures and be asked to return 6 months later (9 months) for longer-term follow-up measures.

Conditions

Interventions

TypeNameDescription
BEHAVIORALTraditional Healthy Lifestyle ProgramTwice weekly meetings that focus on nutrition and exercise for 12 weeks.
BEHAVIORALMindfulness Meditation InstructionParticipants receive six mindfulness sessions.

Timeline

Start date
2018-01-11
Primary completion
2021-03-30
Completion
2021-03-30
First posted
2018-08-02
Last updated
2021-06-11

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT03611660. Inclusion in this directory is not an endorsement.